To evaluate the potential of CCL25 to induce cell migration of AF-derived cells, concentrations of 500, 750 and 1000 nM CCL25 were applied in the Boyden-chamber chemotaxis assay. The gene discussed is CCL25; the disease is atrial fibrillation.